0001607062-22-000004.txt : 20220107 0001607062-22-000004.hdr.sgml : 20220107 20220107172220 ACCESSION NUMBER: 0001607062-22-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220105 FILED AS OF DATE: 20220107 DATE AS OF CHANGE: 20220107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PETKANAS DEAN CENTRAL INDEX KEY: 0000944235 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55657 FILM NUMBER: 22518979 MAIL ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROPATHIX, INC. CENTRAL INDEX KEY: 0001615999 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462645343 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 BUSINESS PHONE: 858-883-2642 MAIL ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 FORMER COMPANY: FORMER CONFORMED NAME: Neuropathix, Inc. DATE OF NAME CHANGE: 20201112 FORMER COMPANY: FORMER CONFORMED NAME: Kannalife Inc DATE OF NAME CHANGE: 20181113 FORMER COMPANY: FORMER CONFORMED NAME: TYG Solutions Corp. DATE OF NAME CHANGE: 20140821 4 1 ownership.xml X0306 4 2022-01-05 0 0001615999 NEUROPATHIX, INC. NPTX 0000944235 PETKANAS DEAN 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 1 1 1 0 Chief Executive Officer Common Stock 2022-01-05 4 S 0 89000 0.047 D 24770029 I See Note Common Stock 2022-01-06 4 S 0 120000 0.051 D 24650029 I See Note Common Stock 2022-01-07 4 S 0 41000 0.046 D 24609029 I See Note Common Stock 2022-01-07 4 G 0 300000 0.00 D 24309029 I See Note Common Stock 2022-01-07 4 G 0 250000 0.00 D 24059029 I See Note The sales reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person. These shares were sold in multiple transactions at prices falling within those ranges set forth in footnotes (3) and (5) of this Form 4. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the relevant footnotes. These shares were sold in multiple transactions at prices ranging from $0.045 to $0.050, inclusive. These shares were sold in multiple transactions at prices ranging from $0.045 to $0.050, inclusive. Aggregate amount of shares beneficially owned by the reporting person includes shares held by him directly as well as indirectly through Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC. The reporting person disclaims beneficial ownership of the securities held by Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC, except to the extent of his pecuniary interest therein. Represents a gift of shares by Golden Gate Capital Partners, LLC. /s/ Dean Petkanas 2022-01-07